Home/Filings/4/0001209191-23-039884
4//SEC Filing

Terrillion Scott 4

Accession 0001209191-23-039884

CIK 0001346830other

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 4:09 PM ET

Size

5.2 KB

Accession

0001209191-23-039884

Insider Transaction Report

Form 4
Period: 2023-06-23
Terrillion Scott
SEC'Y; CHIEF COMPLIANCE & G.C.
Transactions
  • Sale

    Common Stock

    2023-06-23$3.51/sh2,483$8,71588,563 total
Footnotes (1)
  • [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on September 7, 2018 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1
  • filerCIK 0001706426

Filing Metadata

Form type
4
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:09 PM ET
Size
5.2 KB